TSBX Insider Trading Activity and SEC Form 4 Filings
TSBX insider trading summary
No open-market insider purchases or sales of Turnstone Biologics Corp. (TSBX) have been reported on SEC Form 4 in the past 12 months.
Latest TSBX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 25, 2023 | Versant Affiliates Fund V, L.P. | 10% Owner | Buy | $2.4M (197,458 @ $12.00) |
| Jul 25, 2023 | Versant Ventures V GP-GP (Canada), Inc. | 10% Owner | Buy | $2.4M (197,458 @ $12.00) |
| Jul 25, 2023 | Davis Jerel | Director | Buy | $2.4M (197,458 @ $12.00) |
| Jul 25, 2023 | Davis Jerel | Director | Buy | $180K (15,028 @ $12.00) |
| Jul 25, 2023 | Davis Jerel | Director | Buy | $79K (6,575 @ $12.00) |
| Jul 25, 2023 | Davis Jerel | Director | Buy | $71K (5,939 @ $12.00) |
| Jul 25, 2023 | Versant Ventures V, LLC | 10% Owner | Buy | $2.4M (197,458 @ $12.00) |
| Jul 25, 2023 | Versant Venture Capital V, L.P. | 10% Owner | Buy | $2.4M (197,458 @ $12.00) |
| Jul 25, 2023 | Versant Ophthalmic Affiliates I, L.P. | 10% Owner | Buy | $2.4M (197,458 @ $12.00) |
| Jul 25, 2023 | Versant Ventures V (Canada), L.P. | 10% Owner | Buy | $2.4M (197,458 @ $12.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.